| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785483 | Bulletin du Cancer | 2018 | 7 Pages |
Abstract
Ready-to-administer bags of gemcitabine allow relevant coverage of manufacturing doses. The annual extra cost would reach 37,200 ⬠for our establishment. But, it can be justified by expected benefits: safer medication circuit, saving time of pharmacy technicianâ¦
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Marion Pouplin, Barbara Lortal,